4,128
Views
30
CrossRef citations to date
0
Altmetric
Reviews

Nanomedicines: a theranostic approach for hepatocellular carcinoma

, &
Pages 680-690 | Received 20 May 2017, Accepted 28 Aug 2017, Published online: 08 Sep 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Afreen Usmani, Anuradha Mishra, Md Arshad & Asif Jafri. (2019) Development and evaluation of doxorubicin self nanoemulsifying drug delivery system with Nigella Sativa oil against human hepatocellular carcinoma. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 933-944.
Read now
Haoping Xu, Changyu He, Ying Liu, Jinling Jiang & Tao Ma. (2018) Novel therapeutic modalities and drug delivery – erlotinib liposomes modified with galactosylated lipid: in vitro and in vivo investigations. Artificial Cells, Nanomedicine, and Biotechnology 46:8, pages 1902-1907.
Read now
Yisong Xu, Cheng Zhang, Hui Liang, Shanshuang Hu, Pengkun Li, Linna Liu, Xianglong Duan, Chao Chen, Yani Zhang & Penggao Dai. (2018) Dishevelled 1, a pivotal positive regulator of the Wnt signalling pathway, mediates 5-fluorouracil resistance in HepG2 cells. Artificial Cells, Nanomedicine, and Biotechnology 46:sup2, pages 192-200.
Read now
Yeonho Jo, Nakwon Choi, Hong Nam Kim & Jonghoon Choi. (2018) Probing characteristics of cancer cells cultured on engineered platforms simulating different microenvironments. Artificial Cells, Nanomedicine, and Biotechnology 46:sup1, pages 1170-1179.
Read now
Yu Zhang, Tao Zhou, Li Luo, Zheng Cui, Na Wang, Yamin Shu & Kai-Ping Wang. (2018) Pharmacokinetics, biodistribution and receptor mediated endocytosis of a natural Angelica sinensis polysaccharide. Artificial Cells, Nanomedicine, and Biotechnology 46:sup1, pages 254-263.
Read now

Articles from other publishers (25)

Sanya Batheja, Rakesh Kumar Sahoo, Sofiya Tarannum, Klaudi K. Vaiphei, Shikha Jha, Amit Alexander, Amit Kumar Goyal & Umesh Gupta. (2023) Hepatocellular carcinoma: Preclinical and clinical applications of nanotechnology with the potential role of carbohydrate receptors. Biochimica et Biophysica Acta (BBA) - General Subjects 1867:10, pages 130443.
Crossref
Sayali Pravin Metkar, Gasper Fernandes, Prerana D. Navti, Ajinkya N. Nikam, Ritu Kudarha, Namdev Dhas, Raviraja N Seetharam, Krishnan Venkata Santhosh, Bola Sadashiva Satish Rao & Srinivas Mutalik. (2023) Nanoparticle drug delivery systems in hepatocellular carcinoma: A focus on targeting strategies and therapeutic applications. OpenNano 12, pages 100159.
Crossref
Mahsa Sedighi, Zahra Mahmoudi, Samin Abbaszadeh, Mohammad Reza Eskandari, Morvarid Saeinasab & Farshid Sefat. (2023) Nanomedicines for hepatocellular carcinoma therapy: Challenges and clinical applications. Materials Today Communications 34, pages 105242.
Crossref
Xuanping Zhao, Chuan Liu, Zichao Wang, Yingyuan Zhao, Xuyang Chen, Haizhen Tao, Hong Chen, Xueqin Wang & Shaofeng Duan. (2023) Synergistic Pro-Apoptotic Effect of a Cyclic RGD Peptide-Conjugated Magnetic Mesoporous Therapeutic Nanosystem on Hepatocellular Carcinoma HepG2 Cells. Pharmaceutics 15:1, pages 276.
Crossref
Yang Wang, Jun Chen, Jiekang Tian, Guanchen Wang, Weikang Luo, Zebing Huang, Yan Huang, Ning Li, Mingming Guo & Xuegong Fan. (2022) Tryptophan-sorbitol based carbon quantum dots for theranostics against hepatocellular carcinoma. Journal of Nanobiotechnology 20:1.
Crossref
Ying Xu, Peng Chen, Lei Tang, Xiaojun Zhang, Feng Shi, Xuyang Ning, Jingli Bi, Yang Qu & Hongfei Liu. (2022) Hypoxia responsive and tumor-targeted mixed micelles for enhanced cancer therapy and real-time imaging. Colloids and Surfaces B: Biointerfaces 215, pages 112526.
Crossref
Yang Guang. (2022) Ligand-modified Nanomaterials for Specific Targeting of Hepatocellular Carcinoma. Journal of Modern Nanotechnology 2:1.
Crossref
Neha Merchant, Sujatha Peela, Afroz Alam & Ganji Purnachandra Nagaraju. 2022. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3 161 174 .
Zhanxia Zhang, Junqian Zhang, Jianhui Tian & Hegen Li. (2021) A polydopamine nanomedicine used in photothermal therapy for liver cancer knocks down the anti-cancer target NEDD8-E3 ligase ROC1 (RBX1). Journal of Nanobiotechnology 19:1.
Crossref
Nahed Abdel-Aziz, Sawsan M. El-Sonbaty & Marwa G. A. Hegazy. (2021) Ameliorative potential of manganese nanoparticles with low-level ionizing radiation against experimentally induced hepatocarcinogenesis. Environmental Science and Pollution Research 28:46, pages 65474-65486.
Crossref
Mohammed Mehadi Hassan Chowdhury, Christiancel Joseph J. Salazar & Md Nurunnabi. (2021) Recent advances in bionanomaterials for liver cancer diagnosis and treatment. Biomaterials Science 9:14, pages 4821-4842.
Crossref
Abdulsalam Alhalmi, Sarwar Beg, Kanchan Kohli, Md. Waris & Tanuja Singh. (2021) Nanotechnology Based Approach for Hepatocellular Carcinoma Targeting. Current Drug Targets 22:7, pages 779-792.
Crossref
Muhammed H. Elnaggar, Abdelrahman I. Abushouk, Ahmed H.E. Hassan, Hadeer M. Lamloum, Amira Benmelouka, Shurouk A. Moatamed, Hossam Abd-Elmegeed, Somia Attia, Aya Samir, Nouran Amr, Dina Johar & Samy Zaky. (2021) Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma. Seminars in Cancer Biology 69, pages 91-99.
Crossref
Devaraj Ezhilarasan & Roy Anitha. 2021. Advanced Drug Delivery Systems in the Management of Cancer. Advanced Drug Delivery Systems in the Management of Cancer 217 223 .
Joseph T. Nandhini, Devaraj Ezhilarasan & Shanmugam Rajeshkumar. (2020) An ecofriendly synthesized gold nanoparticles induces cytotoxicity via apoptosis in HepG2 cells . Environmental Toxicology 36:1, pages 24-32.
Crossref
Tanmoy Dutta, Asoke P. Chattopadhyay, Narendra Nath Ghosh, Somanjana Khatua, Krishnendu Acharya, Subhajit Kundu, Debarati Mitra & Mahuya Das. (2020) Biogenic silver nanoparticle synthesis and stabilization for apoptotic activity; insights from experimental and theoretical studies. Chemical Papers 74:11, pages 4089-4101.
Crossref
Saleh A. Alanazi, Fars Alanazi, Nazrul Haq, Faiyaz Shakeel, Mohamed M. Badran & Gamaleldin I. Harisa. (2020) Lipoproteins-Nanocarriers as a Promising Approach for Targeting Liver Cancer: Present Status and Application Prospects. Current Drug Delivery 17:10, pages 826-844.
Crossref
Chao LiuMeng ZhangJisen ZhaoXinshu ZhuLing ZhuMengdan YanXiaoxian ZhangRui Zhang. (2020) LncRNA FOXD3-AS1 Mediates AKT Pathway to Promote Growth and Invasion in Hepatocellular Carcinoma Through Regulating RICTOR. Cancer Biotherapy and Radiopharmaceuticals 35:4, pages 292-300.
Crossref
Sue Anne Chew, Stefania Moscato, Sachin George, Bahareh Azimi & Serena Danti. (2019) Liver Cancer: Current and Future Trends Using Biomaterials. Cancers 11:12, pages 2026.
Crossref
Aidan Tinafar, Katariina Jaenes & Keith Pardee. (2019) Synthetic Biology Goes Cell-Free. BMC Biology 17:1.
Crossref
Afreen Usmani, Anuradha Mishra, Asif Jafri, Md Arshad & Mohd Aftab Siddiqui. (2019) Green Synthesis of Silver Nanocomposites of Nigella sativa Seeds Extract for Hepatocellular Carcinoma. Current Nanomaterials 4:3, pages 191-200.
Crossref
Satya Prakash Singh, Anup Kumar Sirbaiya & Anuradha Mishra. (2019) Bioinspired Smart Nanosystems in Advanced Therapeutic Applications. Pharmaceutical Nanotechnology 7:3, pages 246-256.
Crossref
Badriya Baig, Sulafa Abdel Halim, Aaminah Farrukh, Yaser Greish & Amr Amin. (2019) Current status of nanomaterial-based treatment for hepatocellular carcinoma. Biomedicine & Pharmacotherapy 116, pages 108852.
Crossref
Kailash C. Petkar. 2019. Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics. Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics 35 56 .
Athanasios Skouras, Konstantina Papadia, Spyridon Mourtas, Pavlos Klepetsanis & Sophia G. Antimisiaris. (2018) Multifunctional doxorubicin-loaded magnetoliposomes with active and magnetic targeting properties. European Journal of Pharmaceutical Sciences 123, pages 162-172.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.